| Literature DB >> 35805585 |
Wolfgang Gruber1,2, Florian Stehling1, Christopher Blosch1, Stefanie Dillenhoefer3, Margarete Olivier1, Cordula Koerner-Rettberg4, Sivagurunathan Sutharsan5, Uwe Mellies1, Christian Taube5, Matthias Welsner5.
Abstract
BACKGROUND: The aim of this study was to investigate the effects of a monitored exercise program on aerobic fitness in children with cystic fibrosis (CF).Entities:
Keywords: VO2peak; aerobic fitness; children; cystic fibrosis; long-term exercise program; physical activity
Mesh:
Year: 2022 PMID: 35805585 PMCID: PMC9265477 DOI: 10.3390/ijerph19137923
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Selection flowchart of participants.
Figure 2Timeline of CFmobile exercise program.
Anthropometric characteristics, lung function, and steps/day of the CFmobil participants at baseline and end.
| Participants (n = 6) | |||||
|---|---|---|---|---|---|
| Mean ± SD T1 | Mean ± SD T3 | Mean ± SD T4 | Chi-Quadrat | ||
| Age (years) | 11.3 ± 3.3 | ||||
| Height (cm) | 143.6 ± 10.3 | 146.2 ± 13.0 | 147.6 ± 11.7 * | 9.652 | 0.008 |
| Weight (kg) | 38.2 ± 10.0 | 38.5 ± 9.8 | 40.2 ± 10.8 | 4.261 | 0.119 |
| BMI | 18.2 ± 2.5 | 17.8 ± 2.4 | 18.0 ± 2.4 | 0.933 | 0.627 |
| ppFEV1 | 102.5 ± 13.1 | 104.0 ± 8.7 | 92.3 ± 9.4 * | 6.333 | 0.042 |
| ppFVC | 94.0 ± 13.7 | 95.3 ± 7.5 | 94.0 ± 11.1 | 0.333 | 0.846 |
| Steps/day | 10,791 ± 2103 | 10,835 ± 1072 | 10,298 ± 1905 | 1.600 | 0.449 |
| Sedentary intensity (<1.5 METs) min/day | 821.0 ± 116.7 | 724.0 ± 96.2 | 744.0 ± 107.9 | 2.800 | 0.247 |
| Light intensity (1.5–3 METs) min/day | 416.2 ± 71.6 | 442.0 ± 61.2 | 397.7 ± 75.6 | 0.737 | 0.692 |
| Moderate-to-vigorous intensity (3–5.9 METs) min/day | 107.3 ± 80.7 | 116.6 ± 66.3 | 97.3 ± 69.9 | 2.632 | 0.268 |
| Vigorous intensity (>6 METs) min/day | 16.3 ± 11.0 | 18.6 ± 14.3 | 16.8 ± 11.0 | 3.500 | 0.174 |
Abbreviations as described in text; T1 = baseline, T3 = after 6 months, T4 = end of program (12 months); Friedman two-way Analysis of Variance (ANOVA) by Ranks Test; between time points of measurement Wilcoxon Test * = p <0.05.
Exercise capacity at baseline and end of the monitored exercise program, CFmobil.
| TG (n = 6) | |||||
|---|---|---|---|---|---|
| Mean ± SD T1 | Mean ± SD T3 | Mean ± SD T4 | Chi-Quadrat | ||
| VO2peak (mL/kg/min) | 39.5 ± 8.7 | 43.4 ± 9.3 | 41.2 ± 7.1 | 1.600 | 0.449 |
| VO2peak (%pred) | 88.6 ± 18.6 | 95.0 ± 18.2 | 91.0 ± 17.6 | 2.211 | 0.331 |
| BR (%) | 68.9 ± 17.0 | 74.3 ± 13.8 | 78.8 ± 11.8 | 0.400 | 0.819 |
| Wpeak (Watt/kg) | 2.9 ± 0.8 | 3.2 ± 0.6 | 3.1 ± 0.6 | 2.666 | 0.264 |
| Wpeak(%pred) | 95.5 ± 26.3 | 107.3 ± 22.8 | 104.0 ± 26.3 | 2.311 | 0.311 |
| HFpeak (b/min) | 184.8 ± 13.1 | 183.3 ± 14.3 | 183.0 ± 17.1 | 0.609 | 0.738 |
| HFpeak (%/peak) | 94.8 ± 6.7 | 94.0 ± 7.4 | 93.8 ± 8.8 | 0.609 | 0.738 |
Abbreviations as described in text; T1 = baseline, T3 = end of monitored exercise program (6 months), T4 = end of program (12 months); Friedman two-way Analysis of Variance (ANOVA) by Ranks Test.
Figure 3Increase in CPET parameters in percent over the course of the 12months partially monitored exercise program.
Figure 4In crease of VO2peak over the course of the 12months partially monitored exercise program.